14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:AGTC
Delisted

Applied Genetic Technologies Corporation Stock Price (Quote)

$0.397
+0 (+0%)
At Close: Feb 28, 2023

Range Low Price High Price Comment
30 days $141.16 $183.01 Tuesday, 28th Feb 2023 AGTC stock ended at $0.397. During the day the stock fluctuated 0% from a day low at $0.397 to a day high of $0.397.
90 days $141.16 $227.30
52 weeks $84.73 $227.30

Historical Applied Genetic Technologies Corporation prices

Date Open High Low Close Volume
Aug 01, 2019 $3.88 $4.04 $3.85 $3.89 61 966
Jul 31, 2019 $3.93 $4.19 $3.86 $3.86 46 359
Jul 30, 2019 $3.98 $4.03 $3.88 $3.90 48 928
Jul 29, 2019 $3.92 $4.02 $3.89 $3.91 22 302
Jul 26, 2019 $3.89 $4.12 $3.89 $3.95 52 115
Jul 25, 2019 $4.07 $4.16 $3.96 $4.02 68 897
Jul 24, 2019 $4.08 $4.10 $3.98 $4.02 117 119
Jul 23, 2019 $3.92 $4.09 $3.88 $4.06 100 424
Jul 22, 2019 $3.98 $4.08 $3.86 $3.91 113 070
Jul 19, 2019 $3.86 $4.03 $3.86 $3.88 196 082
Jul 18, 2019 $3.85 $3.99 $3.85 $3.88 52 362
Jul 17, 2019 $3.84 $4.03 $3.82 $3.88 68 482
Jul 16, 2019 $3.80 $4.07 $3.74 $3.79 185 851
Jul 15, 2019 $3.67 $3.86 $3.67 $3.80 24 424
Jul 12, 2019 $3.73 $3.93 $3.67 $3.67 38 296
Jul 11, 2019 $3.74 $3.91 $3.71 $3.75 22 901
Jul 10, 2019 $3.74 $3.98 $3.72 $3.74 75 510
Jul 09, 2019 $3.73 $3.90 $3.70 $3.75 57 014
Jul 08, 2019 $3.82 $3.88 $3.65 $3.70 49 503
Jul 05, 2019 $3.65 $3.83 $3.65 $3.78 34 791
Jul 03, 2019 $3.63 $3.69 $3.55 $3.66 19 847
Jul 02, 2019 $3.71 $3.79 $3.61 $3.63 60 704
Jul 01, 2019 $3.80 $3.84 $3.70 $3.70 50 961
Jun 28, 2019 $3.70 $3.82 $3.68 $3.79 29 452
Jun 27, 2019 $3.79 $3.79 $3.70 $3.75 11 596
Click to get the best stock tips daily for free!

About Applied Genetic Technologies Corporation

Applied Genetic Technologies Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing... AGTC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT